share_log

China SXT Pharmaceuticals | 20-F/A: Registration statement / Annual report / Transition report (Amendment)

SEC announcement ·  May 20, 2023 05:16
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.